×

Browse

AASLD-EASL HBV Endpoints 2022

AASLD-EASL HBV Endpoints 2022

The American Association for Study of Liver Diseases (AASLD) and European Association for Study of the Liver (EASL) will meet to collaborate at HBV Endpoints in Washington, D.C, USA later this year, with a focus on viral hepatitis. The purpose of this congress is to bring together academics, practising physicians, pharmaceutical companies, and patients to discuss therapeutic endpoints and novel approaches to chronic hepatitis B and D.